Back to search
Premenopausal Idiopathic Osteoporosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Premenopausal Idiopathic Osteoporosis trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Premenopausal Idiopathic Osteoporosis trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The overarching goal of the research program is to define optimal treatment for premenopausal women with clinically significant fracture syndromes that require…
The primary goal of the study is to assess the extent to which bisphosphonate therapy will prevent decreases in bone mass that may occur after cessation of deno…
The purpose of this research study is to evaluate antiresorptive therapy with denosumab (Prolia) for prevention of bone loss after stopping teriparatide (TPTD)…
Idiopathic osteoporosis (IOP) is defined as osteoporosis that affects young, otherwise completely healthy individuals with no secondary cause of bone loss. In t…
Idiopathic osteoporosis (IOP) is an uncommon disorder in which otherwise healthy young individuals sustain one or more low-trauma fractures. Teriparatide \[PTH(…